Tahoe Therapeutics: Funding, Investors & Team (Sep 2026)
Tahoe Therapeutics creates AI-driven tools that mimic human cell reactions to aid in drug development. The company's Mosaic platform generates extensive single-cell data showing how drugs interact with various patient cells, primarily focused on oncology. They share their Tahoe-100M dataset, containing millions of single-cell profiles, to help train AI algorithms that construct virtual cell models for better understanding of therapeutics. Recent funding has allowed the company to expand its dataset to one billion cell data points and one million drug-patient interactions, aiming to support the development of more precise medicines in the future.
Tahoe Therapeutics has raised $30.0M across 1 funding round on record, the most recent an undisclosed round of $30.0M announced in Aug 2025.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Tahoe Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Tahoe Therapeutics Funding Rounds
Tahoe Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Tahoe Therapeutics Funding Compared to Other Artificial Intelligence Startups
Tahoe Therapeutics' latest round of $30.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tahoe Therapeutics in Artificial Intelligence and South San Francisco
Companies Similar to Tahoe Therapeutics
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Tahoe Therapeutics Funding FAQs
What does Tahoe Therapeutics do?
Tahoe Therapeutics creates AI-driven tools that mimic human cell reactions to aid in drug development. The company's Mosaic platform generates extensive single-cell data showing how drugs interact with various patient cells, primarily focused on oncology. They share their Tahoe-100M dataset, containing millions of single-cell profiles, to help train AI algorithms that construct virtual cell models for better understanding of therapeutics. Recent funding has allowed the company to expand its dataset to one billion cell data points and one million drug-patient interactions, aiming to support the development of more precise medicines in the future.
How much funding has Tahoe Therapeutics raised?
Tahoe Therapeutics has raised $30.0M across 1 round on record. The most recent is an undisclosed round of $30.0M announced in Aug 2025.
When did Tahoe Therapeutics last raise funding?
Tahoe Therapeutics' most recent funding round on record is an undisclosed round of $30.0M, announced in Aug 2025.
Who founded Tahoe Therapeutics?
FundedIQ lists Nima Alidoust (Founder) at Tahoe Therapeutics.
Where is Tahoe Therapeutics headquartered?
Tahoe Therapeutics is based in South San Francisco, California, United States.
How many employees does Tahoe Therapeutics have?
Tahoe Therapeutics is in the 11-50 employee band.
How does Tahoe Therapeutics' funding compare to other Artificial Intelligence startups?
Tahoe Therapeutics' latest round of $30.0M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Tahoe Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tahoe Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.